PatientsVille.com Logo

Panaldine Side Effects

PatientsVille

Common Panaldine Side Effects


The most commonly reported Panaldine side effects (click to view or check a box to report):

Hepatic Function Abnormal (49)
Pyrexia (33)
Malaise (30)
Liver Disorder (28)
Interstitial Lung Disease (25)
Jaundice (20)
Hepatitis Cholestatic (19)
Thrombotic Thrombocytopenic Purpura (15)
Alanine Aminotransferase Increased (14)
Hepatocellular Damage (13)
Depressed Level Of Consciousness (12)
Haemodialysis (12)
Cytolytic Hepatitis (12)
Thrombocytopenia (11)
Leukopenia (11)
Agranulocytosis (11)
Aspartate Aminotransferase Increased (11)
Nausea (10)
Decreased Appetite (10)
Granulocytopenia (9)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Panaldine Side Effects Reported to FDA



Panaldine Side Effect Report#8698287
Neutropenia, Liver Disorder, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Blood Bilirubin Increased
This is a report of a 77-year-old male patient (weight: NA) from JP, suffering from the following health symptoms/conditions: angina pectoris, who was treated with Panaldine (dosage: NA, start time:
Jun 12, 2012), combined with:
  • Plavix
  • Amiodarone Hydrochloride
  • Meropen
  • Warfarin
  • Pletaal
  • Sigmart
  • Mexirate
  • Pariet
and developed a serious reaction and side effect(s): Neutropenia, Liver Disorder, Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Blood Bilirubin Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Panaldine treatment in male patients, resulting in Neutropenia side effect. The patient was hospitalized.
Panaldine Side Effect Report#8341591-8
Interstitial Lung Disease, Rheumatoid Arthritis, Rheumatoid Lung, Renal Impairment, Condition Aggravated, Pneumonia Bacterial
This report suggests a potential Panaldine (ticlopidine Hydrochloride) Film-coated Tablet Interstitial Lung Disease side effect(s) that can have serious consequences. A 62-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: NA and used Panaldine (ticlopidine Hydrochloride) Film-coated Tablet (dosage: NA) starting
Jan 01, 2008. After starting Panaldine (ticlopidine Hydrochloride) Film-coated Tablet the patient began experiencing various side effects, including: Interstitial Lung Disease, Rheumatoid Arthritis, Rheumatoid Lung, Renal Impairment, Condition Aggravated, Pneumonia BacterialAdditional drugs used concurrently:
  • Tacrolimus (tacrolimu)
  • Famotidine
  • Enbrel (Unk, Subcutaneous)
  • Micardis
  • Rheumatrex (2mg, Qwk 2mg, 1x/day, Oral)
  • Rheumatrex (2mg, Qwk 2mg, 1x/day, Oral)
  • Prednisolone (Unk, Oral 30 Mg, Unk)
  • Prednisolone (Unk, Oral 30 Mg, Unk)
The patient was hospitalized. Although Panaldine (ticlopidine Hydrochloride) Film-coated Tablet demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Interstitial Lung Disease, may still occur.
Panaldine Side Effect Report#7428766-7
Cerebral Infarction, Rash Pruritic, Toxic Skin Eruption, Skin Mass
This Cerebral Infarction problem was reported by a pharmacist from Japan. A 65-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Panaldine (dosage: Unk). The following drugs were being taken at the same time:
  • Norvasc (Unk)
  • Diovan (Unk)
  • Glucobay (Unk)
When using Panaldine, the patient experienced the following unwanted symptoms/side effects: Cerebral Infarction, Rash Pruritic, Toxic Skin Eruption, Skin MassThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cerebral Infarction, may become evident only after a product is in use by the general population.
Panaldine Side Effect Report#7425784-X
Pulmonary Alveolar Haemorrhage
This Pulmonary Alveolar Haemorrhage side effect was reported by a physician from Japan. A 59-year-old male patient (weight:NA) experienced the following symptoms/conditions: cerebral infarction.The patient was prescribed Panaldine (drug dosage: NA), which was initiated on
Jan 14, 2011. Concurrently used drugs:
  • Glufast
  • Actos
  • Atelec
  • Plavix
  • Crestor
  • Diovan
  • Takepron
  • Iressa
.After starting to take Panaldine the consumer reported adverse symptoms, such as: Pulmonary Alveolar HaemorrhageThese side effects may potentially be related to Panaldine. The patient was hospitalized.
Panaldine Side Effect Report#7347116-8
Gastrointestinal Oedema, Diarrhoea, Protein-losing Gastroenteropathy, Gastritis Atrophic, Gastrointestinal Inflammation, Venous Pressure Increased
This is a report of a 13-year-old male patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Panaldine (dosage: 80 Mg, Qd, start time:
Oct 01, 1997), combined with:
  • Norditropin Nordiflex Chu (0.45-0.8 Mg, Unk)
  • Digosin (0.12 Mg, Qd)
  • Leuplin (0.5 Mg, Qd)
  • Renivace (2.2 Mg, Qd)
  • Warfarin K (1.6 Mg, Qd)
  • Tambocor (120 Mg, Qd)
and developed a serious reaction and side effect(s): Gastrointestinal Oedema, Diarrhoea, Protein-losing Gastroenteropathy, Gastritis Atrophic, Gastrointestinal Inflammation, Venous Pressure Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Panaldine treatment in male patients, resulting in Gastrointestinal Oedema side effect. The patient was hospitalized.
Panaldine Side Effect Report#7341965-8
Parkinsonism
This report suggests a potential Panaldine Parkinsonism side effect(s) that can have serious consequences. A 71-year-old male patient (weight: NA) from Japan was diagnosed with the following symptoms/conditions: prophylaxis,insomnia,parkinson's disease,hypertension,constipation and used Panaldine (dosage: Unk) starting
Jan 01, 2006. After starting Panaldine the patient began experiencing various side effects, including: ParkinsonismAdditional drugs used concurrently:
  • Amoban (Unk)
  • Symmetrel (Unk)
  • Amlodipine (Unk)
  • Pursennid (Unk)
  • Pramipexole Hydrochloride Monohydrate (Unk)
  • Landel (Unk)
  • Atelec (Unk)
  • Blopress (Unk)
The patient was hospitalized. Although Panaldine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Parkinsonism, may still occur.
Panaldine Side Effect Report#6163612-3
Disease Progression, Gastrointestinal Haemorrhage, Rash
This Disease Progression problem was reported by a physician from Japan. A male patient (weight: NA) was diagnosed with the following symptoms/conditions: myocardial infarction,lung adenocarcinoma. On
May 29, 2008 this consumer started treatment with Panaldine (dosage: NA). The following drugs were being taken at the same time:
  • Erlotinib
  • Aspirin (Form: Enteric)
  • Amlodin
When using Panaldine, the patient experienced the following unwanted symptoms/side effects: Disease Progression, Gastrointestinal Haemorrhage, RashAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Disease Progression, may become evident only after a product is in use by the general population.
Panaldine Side Effect Report#6140190-6
This Death side effect was reported by a health professional from Japan. A male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Panaldine (drug dosage: 100 Mg), which was initiated on
Nov 15, 2006. Concurrently used drugs:
  • Simvastatin (10 Mg)
  • Clopidogrel (75 Mg)
.After starting to take Panaldine the consumer reported adverse symptoms, such as: These side effects may potentially be related to Panaldine.
Panaldine Side Effect Report#5688822-0
Agranulocytosis, Cerebrovascular Disorder, Dysarthria, Hypotension, Leukopenia, Malaise, Sepsis
This is a report of a 73-year-old male patient (weight: NA) from France, suffering from the following health symptoms/conditions: acute myocardial infarction, who was treated with Panaldine (dosage: NA, start time:
Jul 19, 2001), combined with:
  • Propacall
  • Bufferin
  • Itorol
  • Tenormin
  • Frandol
  • Harnal
  • Lipitor
  • Stogar
and developed a serious reaction and side effect(s): Agranulocytosis, Cerebrovascular Disorder, Dysarthria, Hypotension, Leukopenia, Malaise, Sepsis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Panaldine treatment in male patients, resulting in Agranulocytosis side effect. The patient was hospitalized.
Panaldine Side Effect Report#5685064-X
Blood Bilirubin Increased, Cerebral Arteriosclerosis, Cholestasis, Coma Hepatic, Dementia, Depressed Level Of Consciousness, Headache, Hepatic Enzyme Increased, Hepatic Failure
This report suggests a potential Panaldine Blood Bilirubin Increased side effect(s) that can have serious consequences. A 70-year-old male patient (weight: NA) from France was diagnosed with the following symptoms/conditions: transient ischaemic attack and used Panaldine (dosage: NA) starting
Aug 12, 1999. After starting Panaldine the patient began experiencing various side effects, including: Blood Bilirubin Increased, Cerebral Arteriosclerosis, Cholestasis, Coma Hepatic, Dementia, Depressed Level Of Consciousness, Headache, Hepatic Enzyme Increased, Hepatic FailureAdditional drugs used concurrently: NA.The patient was hospitalized. Although Panaldine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Blood Bilirubin Increased, may still occur.
Panaldine Side Effect Report#5672296-X
Neutrophil Count Decreased
This Neutrophil Count Decreased problem was reported by a physician from Japan. A 58-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Dec 16, 2007 this consumer started treatment with Panaldine (dosage: NA). The following drugs were being taken at the same time:
  • Aspirin (Unk, Unk)
  • Takepron
  • Fluvastatin
  • Diovan
When using Panaldine, the patient experienced the following unwanted symptoms/side effects: Neutrophil Count DecreasedThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Neutrophil Count Decreased, may become evident only after a product is in use by the general population.
Panaldine Side Effect Report#5632927-7
Neutrophil Count Decreased
This Neutrophil Count Decreased side effect was reported by a physician from Japan. A 58-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Panaldine (drug dosage: NA), which was initiated on
Dec 16, 2007. Concurrently used drugs:
  • Aspirin
  • Lansoprazole
  • Fluvastatin
  • Diovan
.After starting to take Panaldine the consumer reported adverse symptoms, such as: Neutrophil Count DecreasedThese side effects may potentially be related to Panaldine. The patient was hospitalized.
Panaldine Side Effect Report#5577965-8
Eczema, Hepatic Function Abnormal, Hepatocellular Damage
This is a report of a 79-year-old male patient (weight: NA) from France, suffering from the following health symptoms/conditions: NA, who was treated with Panaldine (dosage: NA, start time:
Jul 14, 2007), combined with: NA. and developed a serious reaction and side effect(s): Eczema, Hepatic Function Abnormal, Hepatocellular Damage after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Panaldine treatment in male patients, resulting in Eczema side effect. The patient was hospitalized.
Panaldine Side Effect Report#5572993-0
Agranulocytosis, Pharyngeal Ulceration, Pharyngolaryngeal Pain, Pyrexia, Stomatitis
This report suggests a potential Panaldine Agranulocytosis side effect(s) that can have serious consequences. A 47-year-old male patient (weight: NA) from France was diagnosed with the following symptoms/conditions: cerebral infarction and used Panaldine (dosage: NA) starting
Nov 11, 2006. After starting Panaldine the patient began experiencing various side effects, including: Agranulocytosis, Pharyngeal Ulceration, Pharyngolaryngeal Pain, Pyrexia, StomatitisAdditional drugs used concurrently:
  • Cerocral
The patient was hospitalized. Although Panaldine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Agranulocytosis, may still occur.
Panaldine Side Effect Report#5534423-4
Dysgeusia, Loss Of Consciousness
This Dysgeusia problem was reported by a pharmacist from France. A 72-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: percutaneous coronary intervention. On
Oct 12, 2007 this consumer started treatment with Panaldine (dosage: NA). The following drugs were being taken at the same time: NA. When using Panaldine, the patient experienced the following unwanted symptoms/side effects: Dysgeusia, Loss Of ConsciousnessAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Dysgeusia, may become evident only after a product is in use by the general population.
Panaldine Side Effect Report#5525652-4
Hepatic Function Abnormal, Interstitial Lung Disease, Pneumocystis Jiroveci Pneumonia
This Hepatic Function Abnormal side effect was reported by a physician from France. A 67-year-old patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Panaldine (drug dosage: NA), which was initiated on
May 21, 2007. Concurrently used drugs: NA..After starting to take Panaldine the consumer reported adverse symptoms, such as: Hepatic Function Abnormal, Interstitial Lung Disease, Pneumocystis Jiroveci PneumoniaThese side effects may potentially be related to Panaldine. The patient was hospitalized.
Panaldine Side Effect Report#5525631-7
Hepatic Function Abnormal, Interstitial Lung Disease, Pneumocystis Jiroveci Pneumonia
This is a report of a 67-year-old patient (weight: NA) from France, suffering from the following health symptoms/conditions: NA, who was treated with Panaldine (dosage: NA, start time:
May 21, 2007), combined with: NA. and developed a serious reaction and side effect(s): Hepatic Function Abnormal, Interstitial Lung Disease, Pneumocystis Jiroveci Pneumonia after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Panaldine treatment in patients, resulting in Hepatic Function Abnormal side effect. The patient was hospitalized.
Panaldine Side Effect Report#5523564-3
Anaemia, Toxic Epidermal Necrolysis, Upper Gastrointestinal Haemorrhage
This report suggests a potential Panaldine Anaemia side effect(s) that can have serious consequences. A 53-year-old male patient (weight: NA) from France was diagnosed with the following symptoms/conditions: myocardial infarction and used Panaldine (dosage: NA) starting
Sep 26, 2007. After starting Panaldine the patient began experiencing various side effects, including: Anaemia, Toxic Epidermal Necrolysis, Upper Gastrointestinal HaemorrhageAdditional drugs used concurrently:
  • Aspirin
  • Mexitil
  • Omepral
  • Omepral
  • Carbenin (Route:intravenous Nos)
  • Minocycline Hcl (Route:intravenous Nos)
  • Insulin
  • Zyloric
The patient was hospitalized. Although Panaldine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Anaemia, may still occur.
Panaldine Side Effect Report#5523498-4
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy, Cerebral Infarction, Dementia, Putamen Haemorrhage
This Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy problem was reported by a health professional from France. A 47-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: cerebral infarction. On
Jan 01, 1994 this consumer started treatment with Panaldine (dosage: NA). The following drugs were being taken at the same time:
  • Amantadine Hcl
When using Panaldine, the patient experienced the following unwanted symptoms/side effects: Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy, Cerebral Infarction, Dementia, Putamen HaemorrhageThe patient was hospitalized and became disabled.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy, may become evident only after a product is in use by the general population.
Panaldine Side Effect Report#5522073-5
Condition Aggravated, Rash Pruritic
This Condition Aggravated side effect was reported by a pharmacist from France. A 75-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Panaldine (drug dosage: Frequency Reported As Every Day.), which was initiated on
Oct 12, 2007. Concurrently used drugs:
  • Plavix (Frequency Reported As Every Day)
  • Aspirin
  • Famotidine
  • Sol-melcort (Dose Reported As 500/125mg)
  • Soldem
  • Rescula
  • Mikelan
  • Flumetholon
.After starting to take Panaldine the consumer reported adverse symptoms, such as: Condition Aggravated, Rash PruriticThese side effects may potentially be related to Panaldine. The patient was hospitalized.
Panaldine Side Effect Report#5519254-3
Anaemia, Hepatic Enzyme Increased, Pancytopenia, Pneumonia, Toxic Epidermal Necrolysis
This is a report of a 71-year-old male patient (weight: NA) from France, suffering from the following health symptoms/conditions: angina pectoris, who was treated with Panaldine (dosage: Indication For Use: Coronary Artery Stent Insertion/angina Pectoris., start time:
Jun 17, 2007), combined with: NA. and developed a serious reaction and side effect(s): Anaemia, Hepatic Enzyme Increased, Pancytopenia, Pneumonia, Toxic Epidermal Necrolysis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Panaldine treatment in male patients, resulting in Anaemia side effect.
Panaldine Side Effect Report#5517171-6
Hepatic Function Abnormal, Interstitial Lung Disease, Pneumocystis Jiroveci Pneumonia
This report suggests a potential Panaldine Hepatic Function Abnormal side effect(s) that can have serious consequences. A 67-year-old patient (weight: NA) from France was diagnosed with the following symptoms/conditions: NA and used Panaldine (dosage: NA) starting
May 21, 2007. After starting Panaldine the patient began experiencing various side effects, including: Hepatic Function Abnormal, Interstitial Lung Disease, Pneumocystis Jiroveci PneumoniaAdditional drugs used concurrently: NA.The patient was hospitalized. Although Panaldine demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Hepatic Function Abnormal, may still occur.
Panaldine Side Effect Report#5517165-0
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy, Cerebral Infarction, Dementia, Putamen Haemorrhage
This Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy problem was reported by a health professional from France. A 47-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: cerebral infarction. On
Jan 01, 1994 this consumer started treatment with Panaldine (dosage: NA). The following drugs were being taken at the same time:
  • Amantadine Hcl
When using Panaldine, the patient experienced the following unwanted symptoms/side effects: Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy, Cerebral Infarction, Dementia, Putamen HaemorrhageThe patient was hospitalized and became disabled.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts And Leukoencephalopathy, may become evident only after a product is in use by the general population.
Panaldine Side Effect Report#5455059-X
Coma Hepatic, Convulsion, Escherichia Sepsis, Gastric Ulcer Haemorrhage, Gastrointestinal Haemorrhage, Haematemesis, Hepatic Failure, Hepatitis Fulminant, Hepatorenal Syndrome
This Coma Hepatic side effect was reported by a consumer or non-health professional from Japan. A 74-year-old female patient (weight:NA) experienced the following symptoms/conditions: ruptured cerebral aneurysm,hypertension.The patient was prescribed Panaldine (ticlopidine Hydrochloride) (tablet) (ticlopidine Hydrochlor (drug dosage: 200 Mg (100 Mg, 2 In 1 D), Per Oral), which was initiated on
Jun 19, 2007. Concurrently used drugs:
  • Olmesartan Medoxomil (20 Mg (20 Mg, 1 In 1 D), Per Oral)
  • Mucosta (rebamipide) (rebamipide)
  • Norvasc
.After starting to take Panaldine (ticlopidine Hydrochloride) (tablet) (ticlopidine Hydrochlor the consumer reported adverse symptoms, such as: Coma Hepatic, Convulsion, Escherichia Sepsis, Gastric Ulcer Haemorrhage, Gastrointestinal Haemorrhage, Haematemesis, Hepatic Failure, Hepatitis Fulminant, Hepatorenal SyndromeThese side effects may potentially be related to Panaldine (ticlopidine Hydrochloride) (tablet) (ticlopidine Hydrochlor. The patient was hospitalized.
Panaldine Side Effect Report#5234375-0
Eczema
This is a report of a 55-year-old male patient (weight: NA) from France, suffering from the following health symptoms/conditions: angina pectoris, who was treated with Panaldine (dosage: NA, start time:
Nov 02, 2006), combined with:
  • Nicorandil
  • Aspirin
and developed a serious reaction and side effect(s): Eczema after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Panaldine treatment in male patients, resulting in Eczema side effect. The patient was hospitalized.


1 of 9 


The appearance of Panaldine on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Panaldine reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Panaldine Side Effects

    Did You Have a Panaldine Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Panaldine for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Panaldine Safety Alerts, Active Ingredients, Usage Information

    More About Panaldine

    Side Effects reported to FDA: 210

    Panaldine safety alerts: No

    Reported deaths: 24

    Reported hospitalizations: 162

    Latest Panaldine clinical trials

    Panaldine Reviews

    No reviews, be a first to report a side effect via side effect reporting form